English
Back
Open Account
Institutional Q2 Holdings Revealed! What Is "Smart Money" Buying?
牛牛名人追蹤
joined discussion · ·

Tracking Cathie Wood: Significant increase in biotech stock GENB with over 300,000 shares added, continuing to adjust portfolio holdings

On Wednesday, August 26, 2026, the three major US stock indices closed slightly lower collectively, with overall market sentiment leaning cautious. The S&P 500 fell 0.02% to close at 7,675.70, the Nasdaq declined 0.08% to 26,130.20, and the Dow Jones dropped 0.21% to 53,463.88. The minor declines across all three indices indicate the market is consolidating at high levels, with bulls and bears in relative balance.
Against the backdrop of broader market volatility, Cathie Wood concentrated her buying power on core targets in precision medicine and AI infrastructure on the day, while reducing positions in several other holdings. This move may aim to lock in capital, streamline the portfolio, and tilt resources toward areas with greater long-term innovation potential.
On Wednesday, August 26, 2026, the three major US stock indices closed slightly lower collectively, with overall market sentiment leaning cautious. The S&P 500 fell 0.02% to close at 7,675.70, the Nasdaq declined 0.08% to 26,130.20, and the Dow Jones dropped 0.21% to 53,463.88. The minor declines across all three indices indicate the market is consolidating at high levels, with bulls and bears in relative balance. Against the backdrop of broader market volatility, Cathie Wood concentrated her buying power on core targets in precision medicine and AI infrastructure on the day, while reducing positions in several other holdings. This move may aim to lock in capital, streamline the portfolio, and tilt resources toward areas with greater long-term innovation potential. Buy Direction: Focus on Precision Medicine and AI Computing Infrastructure $Generate Biomedicines (GENB.US)$ Increased by 304,851 shares, marking the largest transaction of the day. Generate Biomedicines is a biotech company driven by generative AI for protein design; its platform has the potential to significantly compress drug development cycles, aligning closely with ARK's long-term bullish view on the convergence of AI and precision medicine. Such a large-scale increase in position may reflect ARK's strong recognition of the commercial progress of the company's technology platform. $Cerebras Systems (CBRS.US)$ Increased holding by 69,585 shares. Cerebras with its...
Symbols
--
--
--
Buy Direction: Focus on Precision Medicine and AI Computing Infrastructure
$Generate Biomedicines (GENB.US)$ Increased by 304,851 shares, marking the largest transaction of the day. Generate Biomedicines is a biotech company driven by generative AI for protein design; its platform has the potential to significantly compress drug development cycles, aligning closely with ARK's long-term bullish view on the convergence of AI and precision medicine. Such a large-scale increase in position may reflect ARK's strong recognition of the commercial progress of the company's technology platform.
$Cerebras Systems (CBRS.US)$ Increased holdings by 69,585 shares. Cerebras is renowned for its wafer-scale AI chip architecture, offering differentiated competitive advantages in the efficiency of training and inference for large models. It may be viewed by ARK as a crucial component of future AI computing infrastructure. This addition to its position likely reflects ARK's firm conviction in the long-term trend of continuously rising demand for AI computing power.
$Broadcom (AVGO.US)$ Increased holdings by 57,705 shares. Broadcom has established deep competitive advantages in custom AI chips (ASICs) and high-speed network interconnects, with several hyperscale cloud providers being its key customers. ARK's increased stake may indicate optimism about its core supply chain role in the wave of AI data center construction.
$Cloudflare (NET.US)$ Increased holdings by 47,794 shares. Cloudflare is expanding its global edge network from traditional CDN services into high-growth areas such as AI inference edge computing and zero-trust security. ARK's addition to this position suggests it sees a key role for the company in the 'last mile' infrastructure required for the deployment of AI inference.
Sell-side activity: Multiple reductions in holdings to optimize portfolio allocation.
$Tempus AI (TEM.US)$ Largest reduction of the day, with ARK selling 181,919 shares. As an AI-driven precision medicine data platform, Tempus AI's stock price may have accumulated significant gains recently. This reduction could be a routine rebalancing move by ARK, or it may be freeing up capital for the substantial increase in its GENB position.
$Twist Bioscience (TWST.US)$ Reduced holdings by 53,280 shares. Twist holds a significant position in the synthetic biology DNA synthesis sector, with year-to-date gains exceeding 300%. However, commercialization in this赛道 has been slow. ARK's recent portfolio adjustment may reflect an assessment that near- to mid-term catalysts are insufficient, leading to a reallocation of capital toward targets with stronger near-term growth momentum.
$Advanced Micro Devices (AMD.US)$ Reduced holdings by 37,977 shares. AMD continues to expand its share in the AI GPU market, but the competitive landscape remains intense. This slight reduction may represent a structural rebalancing within ARK's AI chip sector, shifting capital from AMD to more differentiated targets like Cerebras.
$Robinhood (HOOD.US)$ Reduced holdings by 25,009 shares. As a retail investment platform, Robinhood's growth narrative is linked to ARK's core theme of 'disruptive innovation,' but its growth elasticity may have weakened in the current macroeconomic environment. This reduction is likely part of an overall portfolio optimization strategy.
$Brera Holdings (SLMT.US)$ Reduced holdings by 25,000 shares. Brera Holdings is a holding company focused on the sports sector with a relatively small scale. This reduction may reflect ARK's effort to streamline non-core holdings and narrow the industry coverage of its portfolio.
$Roblox (RBLX.US)$ Reduced holdings by 14,965 shares. Roblox possesses certain unique advantages in the metaverse and user-generated content sectors, but its monetization efficiency and the sustainability of user growth remain questioned by the market. This slight reduction may simply reflect ARK's routine position management within the consumer technology sector.
$CrowdStrike (CRWD.US)$ Reduced holdings by 14,339 shares. CrowdStrike is a long-term holding for ARK and a leader in cybersecurity. This minor reduction is likely just a fine-tuning of its high concentration in the security sector, rather than a bearish signal; it is more likely the result of reallocating capital toward AI infrastructure.
Futubull [Opportunity Page] has launched tracking for celebrity portfolio opportunities! Choose from multiple celebrity holdings, follow big investors' layouts with one click, precisely lock in high-quality targets, and invest with greater confidence!
On Wednesday, August 26, 2026, the three major US stock indices closed slightly lower collectively, with overall market sentiment leaning cautious. The S&P 500 fell 0.02% to close at 7,675.70, the Nasdaq declined 0.08% to 26,130.20, and the Dow Jones dropped 0.21% to 53,463.88. The minor declines across all three indices indicate the market is consolidating at high levels, with bulls and bears in relative balance. Against the backdrop of broader market volatility, Cathie Wood concentrated her buying power on core targets in precision medicine and AI infrastructure on the day, while reducing positions in several other holdings. This move may aim to lock in capital, streamline the portfolio, and tilt resources toward areas with greater long-term innovation potential. Buy Direction: Focus on Precision Medicine and AI Computing Infrastructure $Generate Biomedicines (GENB.US)$ Increased by 304,851 shares, marking the largest transaction of the day. Generate Biomedicines is a biotech company driven by generative AI for protein design; its platform has the potential to significantly compress drug development cycles, aligning closely with ARK's long-term bullish view on the convergence of AI and precision medicine. Such a large-scale increase in position may reflect ARK's strong recognition of the commercial progress of the company's technology platform. $Cerebras Systems (CBRS.US)$ Increased holding by 69,585 shares. Cerebras with its...
Risk Disclaimer: The above content only represents the author's view. It does not represent any position or investment advice of Futu. Futu makes no representation or warranty.Read more
Thumbs Up
10
Respect
1
395K Views
Report
Comment (1)
Write a Comment...
1
11
6